Article
[Polygenic scores and cancer risk].
Medecine sciences : M/S - 1 May 2020
Jordan Bertrand
Abstract excerpt
Risk assessment for a cancer type with moderate heritability can be accurately performed using a relatively small number of SNPs detected by GWAS analyses to calculate a polygenic risk score (PRS) that has definite clinical utility.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
